0      0


JL1113ES - JL1113ES: First Results From SunRISe-1 in Patients With BCG Unresponsive High-Risk Non–muscle-Invasive Bladder Cancer Receiving TAR-200 in Combination With Cetrelimab, TAR-200, or Cetrelimab Alone


‐ Oct 23, 2023 11:00pm

Full author listing

Siamak Daneshmand, MD1 Michiel S. van der Heijden MD,2 Joseph M. Jacob, MD, MCR3 Andrea Necchi MD,4 Evanguelos Xylinas MD,5 David S. Morris MD, FACS6 Philipp Spiegelhalder MD,7 Daniel Zainfeld MD,8 Taek Won Kang MD, PhD,9 Justin T. Matulay MD,10 Laurence H. Belkoff DO, FACOS,11 Karel Decaestecker PhD,12 Harm Arentsen PhD,13 Shalaka Hampras, MBBS, PhD, MPH14 Shu Jin MS,15 Christopher J. Cutie MD, MBA,15 Hussein Sweiti, MD,16 Katharine Stromberg PhD,14 Jason Martin PhD,17 Giuseppe Simone MD18

1Department of Urology, University of Southern California, Norris Comprehensive Cancer Center, Los Angeles, CA; 2Netherlands Cancer Institute, Department of Medical Oncology, Amsterdam, the Netherlands; 3Upstate Medical University, Department of Urology, Syracuse, NY; 4Vita-Salute San Raffaele University, IRCCS San Raffaele Hospital and Scientific Institute, Milan, Italy; 5Department of Urology, Bichat-Claude Bernard Hospital, Assistance-Publique-Hôpitaux de Paris, Université de Paris Cité, Paris, France; 6Urology Associates, Nashville, TN; 7Urologie Neandertal, Gemeinschaftspraxis für Urologie, Mettmann, Germany; 8Urology San Antonio, San Antonio, TX; 9Department of Urology, Chonnam National University Medical School, Chonnam National University Hospital, Gwangju, Korea; 10Atrium Health Levine Cancer Institute, Charlotte, NC; 11MidLantic Urology/Solaris Health, Bala Cynwyd, PA; 12Department of Urology, Ghent University Hospital, Ghent, Belgium; 13AZ Sint-Jan Hospital Brugge-Oostende, Bruges, Belgium; 14Janssen Research & Development, Clinical Oncology, Raritan, NJ; 15Janssen Research & Development, Clinical Oncology, Lexington, MA; 16Janssen Research & Development, Spring House, PA; 17Janssen Research & Development, High Wycombe, UK; 18'Regina Elena' National Cancer Institute, Department of Urology, Rome, Italy


Presenter(s):

You must be logged in and own this session in order to post comments.